3.20
전일 마감가:
$3.32
열려 있는:
$3.3
하루 거래량:
1.70M
Relative Volume:
1.78
시가총액:
$227.34M
수익:
-
순이익/손실:
$-117.81M
주가수익비율:
-1.7021
EPS:
-1.88
순현금흐름:
$74.30M
1주 성능:
-0.31%
1개월 성능:
+0.95%
6개월 성능:
-72.60%
1년 성능:
-18.99%
Omeros Corporation Stock (OMER) Company Profile
명칭
Omeros Corporation
전화
206-676-5000
주소
201 ELLIOTT AVENUE WEST, SEATTLE, WA
OMER을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
OMER
Omeros Corporation
|
3.20 | 227.34M | 0 | -117.81M | 74.30M | -1.88 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Omeros Corporation Stock (OMER) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-10 | 개시 | H.C. Wainwright | Buy |
2024-12-23 | 개시 | D. Boral Capital | Buy |
2024-11-14 | 개시 | Rodman & Renshaw | Buy |
2022-12-08 | 다운그레이드 | UBS | Buy → Neutral |
2022-11-08 | 다운그레이드 | BofA Securities | Neutral → Underperform |
2022-06-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
2021-10-08 | 다운그레이드 | JP Morgan | Neutral → Underweight |
2021-10-01 | 다운그레이드 | Maxim Group | Buy → Hold |
2021-10-01 | 다운그레이드 | Wedbush | Neutral → Underperform |
2021-09-27 | 개시 | JP Morgan | Neutral |
2021-02-01 | 개시 | UBS | Buy |
2020-10-20 | 개시 | BofA Securities | Buy |
2020-08-21 | 재확인 | H.C. Wainwright | Buy |
2020-08-14 | 재확인 | Maxim Group | Buy |
2019-05-06 | 개시 | Cantor Fitzgerald | Overweight |
2018-07-12 | 개시 | Seaport Global Securities | Buy |
2018-03-23 | 다운그레이드 | Wedbush | Outperform → Neutral |
2018-03-05 | 다운그레이드 | Needham | Buy → Hold |
2017-11-08 | 개시 | H.C. Wainwright | Buy |
2017-05-11 | 다운그레이드 | Cantor Fitzgerald | Buy → Neutral |
2017-03-17 | 재확인 | Maxim Group | Buy |
2017-03-17 | 재확인 | Needham | Buy |
2016-11-16 | 재확인 | Wedbush | Outperform |
2016-11-10 | 재확인 | Needham | Buy |
2016-08-10 | 재확인 | Maxim Group | Buy |
2016-06-03 | 개시 | Cantor Fitzgerald | Buy |
2016-03-02 | 재확인 | Needham | Buy |
2016-02-29 | 재확인 | Wedbush | Outperform |
2015-11-11 | 재확인 | Needham | Buy |
2015-08-18 | 재확인 | WBB Securities | Strong Buy |
2015-08-10 | 개시 | ROTH Capital | Buy |
모두보기
Omeros Corporation 주식(OMER)의 최신 뉴스
Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX
Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World
HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World
Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World
Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World
Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga
Trend Tracker for (OMER) - news.stocktradersdaily.com
Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus
Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus
HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener
Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus
Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus
Omeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial Program - mx.advfn.com
Omeros (NASDAQ:OMER) Stock Rating Lowered by Wall Street Zen - Defense World
Omeros Corporation Announces Agreements to Acquire $80.5 Million of its Convertible Senior Notes Due 2026 - mx.advfn.com
OMEROmeros Corporation Reports First Quarter 2025 Financial Results - mx.advfn.com
Squarepoint Ops LLC Has $316,000 Stake in Omeros Co. (NASDAQ:OMER) - Defense World
Millennium Management LLC Buys 27,088 Shares of Omeros Co. (NASDAQ:OMER) - Defense World
Two Sigma Advisers LP Decreases Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Corporation to Host Earnings Call - ACCESS Newswire
Nuveen Asset Management LLC Reduces Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Co. (NASDAQ:OMER) Shares Bought by Two Sigma Investments LP - Defense World
Down 54.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Omeros (OMER) - Yahoo Finance
BNP Paribas Financial Markets Has $74,000 Stock Position in Omeros Co. (NASDAQ:OMER) - Defense World
ProShare Advisors LLC Has $183,000 Position in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros Corporation to acquire $80.5 million of its convertible senior notes due 2026 - MSN
Deutsche Bank AG Has $396,000 Stock Holdings in Omeros Co. (NASDAQ:OMER) - Defense World
Omeros' Note Swap Causes Share Price Tumble - Finimize
Omeros: On The Brink As It Awaits Its Fall PDUFA For A Potential Blockbuster (OMER) - Seeking Alpha
Equities Analysts Issue Forecasts for Omeros FY2025 Earnings - Defense World
Omeros Co. (NASDAQ:OMER) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Omeros (NASDAQ:OMER) Rating Increased to Hold at StockNews.com - Defense World
Omeros signals debt reduction of over $100M and prioritizes narsoplimab launch following FDA BLA acceptance - MSN
Omeros (NASDAQ:OMER) Earns Hold Rating from Needham & Company LLC - Defense World
Omeros Corporation (NASDAQ:OMER) Q1 2025 Earnings Call Transcript - Insider Monkey
Omeros Co. (NASDAQ:OMER) Shares Purchased by Comerica Bank - Defense World
Omeros Corp. Earnings Call: Cautious Optimism Amid Challenges - TipRanks
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic D - GuruFocus
Needham Reiterates Hold Rating on Omeros (OMER) | OMER Stock New - GuruFocus
Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings By Investing.com - Investing.com Nigeria
Omeros: Q1 Earnings Snapshot - CT Insider
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab ... - Yahoo Finance
Omeros Corp (OMER) Q1 2025 Earnings Call Highlights: Strategic Debt Reduction and Narsoplimab Launch Plans - GuruFocus
Omeros (OMER) Achieves Milestone with FDA Acceptance of Narsopli - GuruFocus
Omeros Corporation Reports Q1 2025 Financial Results - TipRanks
Earnings call transcript: Omeros Q1 2025 sees stock rise post-earnings - Investing.com
Omeros (OMER) Streamlines Debt, Preps for Narsoplimab Launch - GuruFocus
Transcript : Omeros Corporation, Q1 2025 Earnings Call, May 15, 2025 - marketscreener.com
Omeros Corp Q1 2025 Earnings: EPS of -$0.58 Misses Estimates, Re - GuruFocus
Omeros reports Q1 EPS (58c), consensus (60c) - TipRanks
Omeros Corporation (OMER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):